Skip to main content
SR biotek Inc. logo

SR biotek Inc. — Investor Relations & Filings

Ticker · 270210 ISIN · KR7270210008 KO Manufacturing
Open in API
Filings indexed 190 across all filing types
Latest filing 2024-06-26 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 270210

About SR biotek Inc.

http://srbiotek.com/

SR biotek Inc. is a biotechnology and cosmeceutical company specializing in the research, development, and manufacturing of innovative skincare products. The company offers comprehensive turnkey OEM/ODM solutions to its partners, covering product development, quality control, and manufacturing. A core strength lies in the development of novel ingredients, highlighted by its proprietary bio-material, RAPHITOX, which utilizes a micro-needle shaped structure. In addition to its manufacturing services, SR biotek also develops its own branded skincare lines.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a decision on a paid-in capital increase (유상증자결정) by SR Biotech. It details the issuance of new shares, the purpose of the capital raise, and includes a correction report (정정신고) regarding the schedule of share issuance and listing. This falls under the category of share issuance and capital changes.
2024-06-26 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership (specifically a third-party allocation capital increase) by a major shareholder, (주)크레이버코퍼레이션, in the company 에스알바이오텍. This type of filing is a mandatory disclosure of significant shareholding changes, which falls under the 'Major Shareholding Notification' category.
2024-06-25 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically, redeemable convertible preferred shares via third-party allocation). It details the number of shares issued, the amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2024-06-24 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the acquisition of shares by '비에이파트너스(유)' and its special related parties in '(주)에스알바이오텍'. This type of filing is specifically used to notify the market and regulators when an entity crosses a significant ownership threshold (typically 5%). In the provided classification schema, this falls under 'Major Shareholding Notification'.
2024-06-20 Korean
[기재정정]증권발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from SR Biotech regarding the results of a securities issuance (specifically a third-party paid-in capital increase). It details the number of shares issued, the amount raised, and provides a correction regarding the documentation (substituting a payment certificate with a balance certificate). This falls under the category of share issuance and capital changes.
2024-06-19 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a third-party paid-in capital increase). It details the number of shares issued, the amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2024-06-17 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.